We are live on ! Find out more
IART icon

Integra LifeSciences
IART

147 hedge funds and large institutions have $1.24B invested in Integra LifeSciences in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 60 increasing their positions, 44 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 44

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

12% more call options, than puts

Call options by funds: $772K | Put options by funds: $691K

5% more capital invested

Capital invested by funds: $1.18B → $1.24B (+$61M)

2% more funds holding

Funds holding: 144 → 147 (+3)

Holders
147
Holders Change
+3
Holders Change %
+2.08%
% of All Funds
4.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
60
Reduced
44
Closed
11
Calls
$772K
Puts
$691K
Net Calls
+$81K
Net Calls Change
-$296K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$18.1M
2
Norges Bank
Norges Bank
Norway
+$9.18M
3
DM
Deerfield Management
New York
+$7.45M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$4.58M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.1M

Top Sellers

Rank Fund Capital Flow
1
Boston Partners
Boston Partners
Massachusetts
-$19.1M
2
MACM
March Altus Capital Management
Connecticut
-$5.93M
3
EIP
Epoch Investment Partners
New York
-$2.82M
4
NG
NatWest Group
United Kingdom
-$2.59M
5
Fisher Asset Management
Fisher Asset Management
Washington
-$1.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$220M -$907K -48,680 -0.4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$72.8M +$1.73M +92,661 +3%
VNIM
3
Vaughan Nelson Investment Management
Texas
$67.1M +$3.08M +165,443 +5%
CIP
4
Champlain Investment Partners
Vermont
$65.5M +$731K +39,217 +1%
BFA
5
BlackRock Fund Advisors
California
$62.1M -$592K -31,796 -1%
Wells Fargo
6
Wells Fargo
California
$59.9M +$1.99M +107,058 +4%
Boston Partners
7
Boston Partners
Massachusetts
$47.5M -$19.1M -1,027,493 -29%
EIP
8
Epoch Investment Partners
New York
$40.3M -$2.82M -151,080 -7%
Victory Capital Management
9
Victory Capital Management
Texas
$37.6M +$2.83M +151,804 +8%
Invesco
10
Invesco
Georgia
$37.5M -$320K -17,150 -0.9%
CI
11
Cambiar Investors
Colorado
$33.4M +$1.2M +64,212 +4%
ClearBridge Investments
12
ClearBridge Investments
New York
$31.5M +$120K +6,458 +0.4%
BIT
13
BlackRock Institutional Trust
California
$31.5M +$948K +50,874 +3%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$30.1M +$4.1M +220,099 +16%
SAM
15
Silvercrest Asset Management
New York
$28.8M +$3.43M +184,320 +14%
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$27.7M +$140K +7,537 +0.5%
Fisher Asset Management
17
Fisher Asset Management
Washington
$25M -$1.91M -102,727 -7%
State Street
18
State Street
Massachusetts
$21.4M -$550K -29,529 -3%
Norges Bank
19
Norges Bank
Norway
$18.9M +$9.18M +492,517 +100%
Goldman Sachs
20
Goldman Sachs
New York
$18.8M +$18.1M +971,093 +12,316%
DM
21
Deerfield Management
New York
$17.4M +$7.45M +399,597 +79%
O
22
OppenheimerFunds
New York
$14.1M +$312K +16,768 +2%
Northern Trust
23
Northern Trust
Illinois
$14.1M -$1.08M -57,922 -7%
Natixis Advisors
24
Natixis Advisors
Massachusetts
$12.5M +$455K +24,411 +4%
RFC
25
Russell Frank Company
Washington
$11.1M +$1.58M +84,961 +17%
1
2 3 4 5

IART Hedge Fund Activity: Q2 2014 in Review

147 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q2 2014, worth a combined $1.24B — up 5.2% from $1.18B a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new IART positions and 11 closed out — a net gain of 3 holders — while 60 added to existing stakes and 44 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $18.1M. The largest seller was Boston Partners, cutting an estimated $19.1M.

  • 147 institutional investors held Integra LifeSciences (IART) as of Q2 2014, up from 144 in Q1 2014.
  • Funds reported $1.24B of Integra LifeSciences stock for Q2 2014, up 5.2% quarter-over-quarter.
  • 14 funds opened new Integra LifeSciences positions in Q2 2014 and 11 closed out, a net change of +3 holders.
  • The largest Integra LifeSciences buyer in Q2 2014 was Goldman Sachs, an estimated $18.1M added.
  • The largest Integra LifeSciences seller in Q2 2014 was Boston Partners, an estimated $19.1M sold.

Based on aggregated 13F filings for Q2 2014.